JMDNA is a Chinese biotechnology company that was founded in 2011 and is based in Shanghai. The company specializes in providing genomic and genetic analysis solutions for both the research and clinical diagnostic markets. JMDNA's offerings include non-invasive prenatal DNA testing, inherited genetic disease screening, cancer genome analysis, personal genome solutions, and integrated genomic services for researchers in the life sciences field. With a focus on next-generation sequencing and bioinformatics, the company has established itself as a leader in genomic innovation technologies in China. The most recent funding round for JMDNA took place on 01 March 2016, with a CNY20.00M Series B investment. The investors in this round were Ping An Ventures and 广州海汇投资管理有限公司. This investment signifies the confidence that notable venture capital firms have in JMDNA's potential for growth and innovation in the biotechnology and healthcare sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | CNY20.00M | 2 |
|
01 Mar 2016 |
| Series A | CNY10.00M | 1 |
|
06 Mar 2014 |
No recent news or press coverage available for JMDNA.
We care about your data, and we'd love to use cookies make your experience better.
